Inferensys

Glossary

DICOM Pseudonymization

The process of replacing identifying DICOM data elements with artificial identifiers or pseudonyms, allowing longitudinal data linkage while protecting the original patient identity.
Data scientist building training data pipeline on laptop, data preprocessing visible, technical workspace.
IDENTITY PROTECTION

What is DICOM Pseudonymization?

DICOM pseudonymization is the process of replacing identifying data elements in a DICOM object with artificial identifiers, or pseudonyms, to protect patient privacy while preserving the ability to link data longitudinally.

DICOM Pseudonymization is a reversible data protection process defined in DICOM Part 15 that replaces direct identifiers, such as the Patient Name (0010,0010) and Medical Record Number (0010,0020), with a consistent, coded pseudonym. Unlike full anonymization, this method maintains referential integrity, allowing researchers to correlate multiple studies from the same patient over time without accessing their true identity.

The core mechanism relies on a secure mapping table or a one-way hashing function with a secret salt to generate the pseudonym. This ensures that the original identity can only be recovered by an authorized party holding the key, making it distinct from irreversible DICOM De-identification. The process is critical for clinical trials and longitudinal research where patient-specific data linkage must be preserved across disparate DICOM data sets.

IDENTITY PROTECTION

Core Characteristics of Pseudonymization

Pseudonymization is a critical data protection technique that replaces direct identifiers in DICOM headers with artificial pseudonyms, enabling longitudinal data linkage while preserving patient privacy.

01

Reversible Identity Mapping

Unlike anonymization, pseudonymization maintains a secure, reversible mapping between the original identifier and the pseudonym. This allows authorized systems to re-identify data if clinically necessary.

  • Uses a master patient index (MPI) or trusted third-party service
  • Original Patient ID (0010,0020) is replaced with a study-specific pseudonym
  • Mapping table is stored in a separate, highly secured database
  • Enables longitudinal studies by linking multiple exams from the same patient
02

DICOM Part 15 Compliance

Pseudonymization follows the DICOM PS3.15 Security and System Management Profiles, specifically the Basic Application Level Confidentiality Profile.

  • Patient Name (0010,0010) is replaced with a coded pseudonym
  • Patient ID (0010,0020) is substituted while preserving referential integrity
  • Other Patient IDs (0010,1000) and Other Patient Names (0010,1001) are cleaned
  • Retains essential clinical metadata: modality, body part, acquisition parameters
03

Longitudinal Data Linkage

The primary advantage of pseudonymization over full anonymization is the ability to track a patient's clinical timeline across multiple studies without knowing their real identity.

  • All exams for Patient X map to the same pseudonym SUBJ-7A3F
  • Enables temporal analysis of disease progression
  • Supports clinical trial cohorts where treatment response must be tracked
  • Critical for radiomics and AI model training on sequential imaging data
04

Private Tag Handling

Medical device vendors often store identifying information in private DICOM tags (odd group numbers) that fall outside standard de-identification profiles.

  • Requires a vendor-specific tag dictionary to locate hidden PHI
  • Private creator blocks (e.g., GEMS_SIEMENS_01) must be audited
  • Burned-in annotations in pixel data must be detected and redacted
  • Unknown private tags should be removed entirely to prevent accidental disclosure
05

Cryptographic Pseudonym Generation

Modern systems use deterministic cryptographic hashing to generate pseudonyms, ensuring the same input always produces the same pseudonym without storing a mapping table.

  • HMAC-SHA256 with a secret salt key produces irreversible pseudonyms
  • Eliminates the risk of a compromised mapping database
  • Same Patient ID + same salt = same pseudonym across all systems
  • Requires strict key management to prevent brute-force reversal
06

Operational Workflow Integration

Pseudonymization is typically deployed as a DICOM proxy service that intercepts and modifies data in transit between modalities and PACS.

  • Acts as a DIMSE or DICOMweb intermediary
  • Processes C-STORE operations in real-time before archival
  • Can be integrated with Modality Worklist (MWL) to pseudonymize at acquisition
  • Maintains an audit log of all transformations for regulatory compliance
IDENTITY MANAGEMENT IN DICOM

Pseudonymization vs. Anonymization

Comparative analysis of data protection techniques for DICOM Protected Health Information (PHI) as defined in DICOM Part 15 and ISO 25237:2017

FeaturePseudonymizationAnonymizationDe-identification

Reversibility

Reversible with key

Irreversible

Irreversible

Patient longitudinal linkage

Retains original Patient ID

Requires trusted third party

DICOM Part 15 profile

Basic Application Confidentiality Profile with pseudonym option

Basic Application Confidentiality Profile

Basic Application Confidentiality Profile

Burned-in annotation removal

Required

Required

Required

Private tag handling

Retained if safe

Removed

Removed

Re-identification risk

Low (controlled)

Minimal

Minimal

DICOM PRIVACY

Frequently Asked Questions

Clear answers to the most common technical and regulatory questions about replacing patient identities in medical imaging data.

DICOM pseudonymization is the process of replacing direct patient identifiers in a DICOM data set with artificial identifiers, or pseudonyms, while preserving the ability to link data belonging to the same patient longitudinally. Unlike DICOM Anonymization, which irreversibly strips all links, pseudonymization retains a mapping table or cryptographic key. The process targets specific DICOM Tags like Patient Name (0010,0010) and Medical Record Number (0010,0020), replacing their values with generated codes. This allows clinical trials and research cohorts to track a patient's imaging history over time without exposing their original identity to downstream researchers, maintaining a critical balance between data utility and privacy compliance under regulations like GDPR.

Prasad Kumkar

About the author

Prasad Kumkar

CEO & MD, Inference Systems

Prasad Kumkar is the CEO & MD of Inference Systems and writes about AI systems architecture, LLM infrastructure, model serving, evaluation, and production deployment. Over 5+ years, he has worked across computer vision models, L5 autonomous vehicle systems, and LLM research, with a focus on taking complex AI ideas into real-world engineering systems.

His work and writing cover AI systems, large language models, AI agents, multimodal systems, autonomous systems, inference optimization, RAG, evaluation, and production AI engineering.